Are all angiotensin-converting enzyme inhibitors interchangeable?
- 1 April 2001
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 37 (5) , 1456-1460
- https://doi.org/10.1016/s0735-1097(01)01161-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effects of Ramipril and Vitamin E on AtherosclerosisCirculation, 2001
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Are drugs within a class interchangeable?The Lancet, 1999
- A COMPARISON OF THE COUGH PROFILE OF FOSINOPRIL AND ENALAPRIL IN HYPERTENSIVE PATIENTS WITH A HISTORY OF ACE INHIBITOR-ASSOCIATED COUGHClinical Journal of Sport Medicine, 1995
- ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarctionThe Lancet, 1995
- Use of 'Xapril' in patients with chronic heart failure. A paradigm or epitaph for our times?Circulation, 1994
- The QUinapril Ischemic Event Trial (QUIET) design and methods: Evaluation of chronic ACE inhibitor therapy after coronary artery interventionCardiovascular Drugs and Therapy, 1993
- Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987